5 Questions: Temple Grandin discusses autism, animal communication
Temple Grandin, an autism-rights activist and professor of animal science at Colorado State University, will discuss autism and animal behavior in a Nov. 19 talk at Stanford.
5 Questions: Why a fashion magazine editor became a dermatologist
Laurel Geraghty, a former editor at Glamour, is now a second-year dermatology resident at the Stanford.
5 Questions: David Relman on risks of creating new pathogens
Biosecurity expert David Relman, MD, asserts that a better approach is needed for assessing the risks and benefits of research involving the creation of new and dangerous infectious agents.
5 Questions: Sanjay Basu on preventing chronic illness in developing nations
Rosenkranz prize winner Sanjay Basu uses mathematical models, statistics and data analysis to battle chronic disease in the developing world.
5 Questions: The story behind the new Stanford Medicine website
The effort to revamp the Stanford Medicine website began two years ago. In this Q&A, Web services director Mark Trenchard describes the process and what Web users can expect in coming months.
5 Questions: Brendan Carvalho on CPR for pregnant patients
When a pregnant woman's heart stops, two lives are threatened.
5 Questions: Ann Arvin on Stanford's history of collaboration
Stanford recently announced two new institutes that bridge departmental and school boundaries — the Stanford Neurosciences Institute and the Stanford Institute for Chemical Biology — bringing the number of university-wide interdisciplinary laboratories, centers and institutes on campus to 18.
5 Questions: Jackler on the rise of e-cigarettes
The use of electronic cigarettes has grown rapidly across the United States, prompting questions about their safety and whether they serve as a gateway to conventional cigarettes or a means of kicking the habit — or at least of sustaining a nicotine addiction without inhaling the carcinogens in smoke.
5 Questions: David Magnus on understanding brain death
When is a person considered dead? Two recent cases have thrust the issue of "brain death" back into the national conversation.
5 Questions: Hannah Valantine discusses progress of diversity efforts at school
Since 2005, Hannah Valantine, MD, has led efforts to foster diversity among faculty, staff and trainees at the School of Medicine, where she is senior associate dean for diversity and leadership and a professor of cardiovascular medicine.
Leading the Biomedical Revolution
We are in the middle of a biomedical revolution more profound and far-reaching than the industrial and digital revolutions that made it possible.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.